In this Review, we examine the concurrent outbreaks of mpox in Africa, focusing on clade 1a, the newly emerged clade 1b, and clade 2b lineage A, and how they differ from the 2022 global outbreak ...

A quality improvement program designed to increase earlier uptake of the human papillomavirus (HPV) vaccine raised ...

Interim data from a phase 3 study evaluating tecovirimat for the treatment of human mpox virus showed the antiviral did not improve time to lesion resolution compared with placebo.

A flu-like disease that has killed dozens of people over two weeks is being investigated in southwestern Congo, local ...

New cases of the disease every week and now more than a thousand deaths: the health authorities in Africa have been battling ...

It is the only vaccine effective against mpox that is approved for use in children, and the pledge was the biggest single donation yet to fight the disease anywhere. Advt But the two countries ...

It is the only vaccine effective against mpox that is approved for use in children ... work includes coverage of gender-affirming care for adolescents in the UK and a global investigation with ...

Last month, WHO also officially approved the use of the mpox vaccine from Danish firm Bavarian Nordic for adolescents aged 12 to 17, a group vulnerable to the disease. In the context of the number of ...

The vaccine is the second to be approved by the UN agency and the first approved for children aged one and older. View on euronews ...

The World Health Organization listed KM Biologics' mpox vaccine for emergency use on Tuesday, November 19, 2024, making it the second shot to get the approval of the global health agency.

Answering the same question, Rimoin says: "The answer is no. Mpox is not new, like COVID. This is a known virus with tools already available to be able to control it, including vaccines.